{
    "code": "52027332",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027332",
    "time": "2019-06-14 03:38:59",
    "許可證字號": "衛部藥輸字第027332號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/12\/04",
    "發證日期": "106\/12\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202733206",
    "中文品名": "阿茲列特錠1毫克",
    "英文品名": "Azilect Tablets",
    "適應症": "為治療原發性巴金森氏症(PD)病患的單一治療藥劑(不合併使用levodopa)，或作為輔助治療藥劑與levodopa同時投予。若屬合併治療，可由每日0.5毫克作為治療劑量。",
    "劑型": "110錠劑",
    "包裝": "2-1000粒ALU-ALU鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "RASAGILINE MESYLATE",
    "主製造廠": {
        "申請商名稱": "620102K944  香港商艾維斯有限公司台灣分公司",
        "申請商地址": "台北市中正區忠孝東路二段116號10樓",
        "主製造廠": "",
        "製造廠名稱": "FIL0037000  TEVA PHARMACEUTICAL INDUSTRIES LTD."
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2816500610",
            "成分名稱": "RASAGILINE MESYLATE",
            "含量描述": "(Equivalent to Rasagiline Base.....1mg)",
            "含量": "1.5600000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Azilect Tablets_201901_中文仿單-108-01-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027332&Seq=002&Type=9"
        },
        {
            "title": "52027332_Azilect Tablets_Carton-108-04-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027332&Seq=004&Type=8"
        },
        {
            "title": "52027332_Azilect Tablets_Blister-108-04-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027332&Seq=003&Type=8"
        }
    ]
}